Anavex® Life Sciences presenting at Society for Neuroscience Nov. 11-15, 2017 in Washington DC

Efficacy of ANAVEX 2-73, a Sigma-1 receptor agonist, in the MECP2 mouse model of Rett syndrome

Share this: